Cannabinoids: from pot to lab

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Papaseit Fontanet, Esther
• dc.contributor.author Pérez Mañá, Clara
• dc.contributor.author Pérez-Acevedo, Ana Pilar
• dc.contributor.author Hladun, Olga
• dc.contributor.author Torres-Moreno, Mari Carmen
• dc.contributor.author Muga, Roberto
• dc.contributor.author Torrens, Marta
• dc.contributor.author Farré Albaladejo, Magí
• dc.date.accessioned 2019-05-28T09:06:43Z
• dc.date.available 2019-05-28T09:06:43Z
• dc.date.issued 2018
• dc.description.abstract Cannabis is becoming increasingly present in our society. In recent years, the line between the natural (cannabis) and the synthetic (synthetic cannabinoids), the recreational (cannabis) and the medical (pharmaceutical cannabinoids and medical cannabis) has been crossed. In this paper we review some of the novel aspects of cannabis and cannabinoids in relation to their legal situation, changes in their composition and forms of cannabis use, the concept of medical cannabis, and synthetic cannabinoids as new psychoactive substances (NPS). We have also analyzed serious adverse reactions and intoxications associated with the use of synthetic cannabinoids, as well as the latest developments in the research of pharmaceutical cannabinoids.
• dc.format.mimetype application/pdf
• dc.identifier.citation Papaseit E, Pérez-Mañá C, Pérez-Acevedo AP, Hladun O, Torres-Moreno MC, Muga R. et al. Cannabinoids: from pot to lab. Int J Med Sci. 2018 Aug 6;15(12):1286-1295. DOI: 10.7150/ijms.27087
• dc.identifier.doi http://dx.doi.org/10.7150/ijms.27087
• dc.identifier.issn 1449-1907
• dc.identifier.uri http://hdl.handle.net/10230/41636
• dc.language.iso eng
• dc.publisher Ivyspring International Publisher
• dc.rights Copyright © Ivyspring International Publisher. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri https://creativecommons.org/licenses/by-nc/4.0/
• dc.subject.keyword Cannabis
• dc.subject.keyword Delta-9-tetrahydrocannabinol (THC)
• dc.subject.keyword Cannabidiol (CBD)
• dc.subject.keyword Medical cannabis
• dc.subject.keyword Synthetic cannabinoid
• dc.subject.other Cannabinoides -- Efectes fisiològics
• dc.title Cannabinoids: from pot to lab
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion